HiRes AGT Logo.jpg
American Gene Technologies to Present at 2019 Cell & Gene Meeting on the Mesa
October 01, 2019 14:51 ET | American Gene Technologies
ROCKVILLE, Md., Oct. 01, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies announced today that its Chief Science Officer C. David Pauza, Ph.D. will present at the annual Cell & Gene Meeting...
HiRes AGT Logo.jpg
HIV Cure Program of American Gene Technologies Adds University of Maryland School of Medicine’s Institute of Human Virology as New Study Site to Support the Development of a Cell and Gene Therapy for HIV
July 02, 2019 16:33 ET | American Gene Technologies
ROCKVILLE, Md., July 02, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies (AGT), a leading gene and cell therapy company based in Rockville, MD, selected the Institute of Human Virology (IHV) at...
HiRes AGT Logo.jpg
HIV Cure Program Patent Granted To American Gene Technologies
May 21, 2019 08:30 ET | American Gene Technologies
ROCKVILLE, Md., May 21, 2019 (GLOBE NEWSWIRE) -- American Gene Technologies, a leading gene and cell therapy company based in Rockville, Md., was granted a second patent for its unique molecule,...
AGT Logo w Name & Slogan_NEW v3.png
American Gene Technologies Congratulates Robert Redfield, M.D., on His Appointment as Director of the Centers for Disease Control and Prevention
March 28, 2018 08:30 ET | American Gene Technologies
ROCKVILLE, Md., March 28, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today congratulates Robert R. Redfield, M.D., on his...
AGT Logo w Name & Slogan_NEW v3.png
American Gene Technologies Gains Additional Immuno-Oncology Patent
March 19, 2018 08:30 ET | American Gene Technologies
ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced receipt of a second immuno-oncology...
AGT Logo w Name & Slogan_NEW v3.png
American Gene Technologies Announces Progress toward Phase I Clinical Trial of AGT103-T for HIV Functional Cure
January 25, 2018 09:30 ET | American Gene Technologies
ROCKVILLE, Md., Jan. 25, 2018 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced completion of the pilot runs of its...
AGT Logo w Name & Slogan_NEW v3.png
American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer through Activation of Gamma Delta T Cells
December 12, 2017 09:00 ET | American Gene Technologies
ROCKVILLE, Md., Dec. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today announced the issuance of U.S. Patent No:...
AGT Logo w Name & Slogan_NEW v3.png
American Gene Technologies Inc. (AGT) Demonstrates Rationale of its Genetic Approach toward developing a Functional Cure for HIV Infection
October 12, 2017 09:00 ET | American Gene Technologies
ROCKVILLE, Md., Oct. 12, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (“AGT”), a gene therapy and technology company focusing on a lentiviral delivery platform, presented...
AGT Logo w Name & Slogan_NEW v3.png
American Gene Technologies Inc. (AGT) CSO, David Pauza, to Present HIV Functional Cure data At The Cell & Gene Meeting on the Mesa
September 26, 2017 09:00 ET | American Gene Technologies
ROCKVILLE, Md., Sept. 26, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a gene technology company focusing on a lentiviral delivery platform, today announced that...
Julia Brown
American Gene Technologies Inc. Appoints Julia R. Brown to its Board of Directors
September 11, 2017 12:29 ET | American Gene Technologies
ROCKVILLE, Md., Sept. 11, 2017 (GLOBE NEWSWIRE) -- American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company with a broad and robust lentiviral drug-development...